Epinephrine, Benadryl®, and the evolving conversation on treatment of anaphylaxis

Watch the recording now

Learn the importance of epinephrine as first-line treatment for anaphylaxis and whether antihistamines have a role during a reaction. Plus, learn how to recognize anaphylaxis, how to manage it, and the latest thinking on treatment guidelines.

What the webinar is about: During this interactive session, with your input provided through polling, our experts will address common concerns about treating anaphylaxis with epinephrine and when antihistamines might be given. As part of this, you’ll gain a better understanding of the signs and symptoms of anaphylaxis and when to use epinephrine. Plus, learn from our experts about discussions underway to evaluate the current protocol of going to the hospital after using this life-saving medication and how that may change. 

Who is speaking:

• Dr. Moshe Ben-Shoshan: Dr. Ben-Shoshan is a physician in the division of Allergy/Immunology at Montreal Children’s Hospital. He has established the largest cross-Canada registries that collect data on the diagnosis and management of food allergy, anaphylaxis, drug allergy, and primary immunodeficiencies; and his research has resulted in more than 100 published manuscripts. Dr. Ben-Shoshan is on the Board of Directors of the Canadian Society of Allergy and Clinical Immunology, on Food Allergy Canada’s Healthcare Advisory Board, and on the steering committee for Canada’s National Food Allergy Action Plan.

• Dr. Jennifer Protudjer: Dr. Protudjer is the Endowed Research Chair in Allergy, Asthma and the Environment, and an associate professor in the Department of Pediatrics and Child Health at the University of Manitoba, an epidemiologist with the Clinical Trials Platform at the George and Fay Yee Center for Healthcare Innovation, and a research scientist at the Children’s Hospital Research Institute of Manitoba.

When was the webinar: Thursday, May 4, 2023 from 12pm to 1pm EDT.